All episodes

Episode 16

AlphaFold 3 and GPT-4o: Revolutionizing Drug Discovery and AI Capabilities

Summary In this episode, Dalton discusses two major topics: Alpha Fold 3 and Chat GPT 4.0. Alpha Fold 3 is a protein structure prediction model that uses machine learning to outperform…

May 14, 202400:31:11
Listen to the episode00:31:11

Summary In this episode, Dalton discusses two major topics: Alpha Fold 3 and Chat GPT 4.0. Alpha Fold 3 is a protein structure prediction model that uses machine learning to outperform physics-based models in drug research and DNA research. It has significant improvements over its predecessor, Alpha Fold 2, and has the potential to accelerate drug discovery and testing. Chat GPT 4.0 is a multimodal AI model that allows users to interact with chatbots using voice, vision, and screen sharing capabilities. Dalton highlights the importance of integrating AI into the human world and the commercialization opportunities for these models.

Episode content

Explore every layer of this episode.

Each article, guide, analysis, and field note has its own focused page and stays linked to this source conversation.

Articles & stories

Narrative and editorial pieces that carry the conversation forward.

12 pieces
Article

OpenAI and the GPT-4o Launch: Company Role

A dated record of OpenAI's role in GPT-4o research, launch, ChatGPT rollout, safety reporting, retirement, and the separate API lifecycle.

1 min read
Article

OpenAI Stargate Project: Scope, Partners, and Evidence

A sourced profile of OpenAI's Stargate infrastructure program, including its planned investment, partners, capacity milestones, current strategy, and evidence limits.

1 min read
Article

Isomorphic Labs' Role in AlphaFold 3

A dated record of Isomorphic Labs' AlphaFold 3 co-development role, drug-design focus, company claims, and the boundary between prediction and outcomes.

1 min read
Article

How to Evaluate a Scientific AI Claim

Identify the exact task, read the original study, inspect the comparator and test data, follow uncertainty, and require real-world validation.

1 min read
Article

GPT-4o Launch: Demo, Rollout, Risks, and Retirement

A dated GPT-4o evidence record separating the May 2024 demonstration, staged ChatGPT rollout, system-card risks, retirement, and API status.

1 min read
Article

Google DeepMind's Role in AlphaFold 3

A dated company and research-role record explaining Google DeepMind's AlphaFold 3 work, joint development, access routes, and evidence boundaries.

1 min read
Article

How to Evaluate a Scientific AI Claim

Audit a scientific AI claim by defining its target, data, comparator, metric, uncertainty, validation, and downstream decision before accepting the headline.

1 min read
Article

How to Evaluate Different Types of AI Systems

Scientific prediction systems and multimodal assistants make different claims. Learn how evidence should follow the task, failure mode, and decision.

1 min read
Article

AlphaFold 3: Paper, Benchmarks, Access, and Limits

A source-led AlphaFold 3 record covering model scope, benchmark conditions, confidence, launch access, academic code and weights, and scientific limits.

1 min read
Article

AlphaFold 3 and GPT-4o Solve Different AI Problems

AlphaFold 3 helps researchers form structural biology hypotheses. GPT-4o reduces interface friction. Each needs a different standard of evidence.

1 min read
Article

AlphaFold 3 and GPT-4o: Science and Usability leaps

How DeepMind's AlphaFold 3 and OpenAI's GPT-4o are reshaping molecular research and real-time human-computer interfaces.

1 min read
Article

AlphaFold 3

AlphaFold 3 is a biomolecular structure-prediction model described by researchers from Google DeepMind and Isomorphic Labs in a Nature paper published on May 8, 2024.

1 min read

Research & analysis

Evidence-led work that tests and expands the claims in the conversation.

8 pieces
Research Note

Scientific AI Claim Audit Protocol

A scientific AI claim should be rewritten before it is judged. Record the exact prediction target, intended use, input, output, data boundary, training cutoff, test set,

1 min read
Research Note

OpenAI GPT-4o Role Record

OpenAI's current about page describes the organization as an AI research and deployment company. It says OpenAI consists of the nonprofit OpenAI Foundation and the for-pr

1 min read
Research Note

Isomorphic Labs AlphaFold 3 Role Record

Isomorphic Labs describes its work as applying AI to drug design. The AlphaFold 3 paper and the May 2024 company launch page identify it as a co-developer with Google Dee

1 min read
Research Note

GPT-4o Demonstration, Rollout, and Lifecycle Record

OpenAI announced GPT-4o on May 13, 2024 as an "omni" model designed to accept combinations of text, audio, image, and video and produce text, audio, and image outputs. Th

1 min read
Research Note

Google DeepMind AlphaFold 3 Role Record

Google DeepMind describes itself as Google's AI research organization, bringing the former DeepMind and Google Brain teams together. Its current about page identifies Dem

1 min read
Research Note

E016 Source-Limited Episode Boundary

The preserved E016 file is a production outline with expanded scripted passages. It records planned wording, topics, interpretations, and source links, but it is not a ti

1 min read
Research Note

Different AI Systems Evidence Matrix

| Question | Scientific prediction system | Multimodal assistant | |---|---|---| | Claimed job | Predict a defined scientific object or relationship | Help a person compl

1 min read
Research Note

AlphaFold 3 Paper and Access Record

The May 2024 Nature paper describes a model for predicting joint structures of complexes that can include proteins, nucleic acids, small molecules, ions, and modified res

1 min read

Full episode

Read the complete record.

The show notes, transcript, and source trail remain on this canonical episode page.

Show notesKey context from the episode.

Dalton Anderson compares AlphaFold 3, a molecular-structure prediction system, with GPT-4o, a multimodal model introduced around voice, vision, and text. The episode asks how each technology could change the work around it.

What the episode covers

SegmentConversation
OpeningWhy AlphaFold 3 and GPT-4o were worth examining together in May 2024
AlphaFold 3A broader range of predicted molecular structures and interactions
Scientific workflowThe possible role of prediction in research and drug discovery
AlphaFold ServerA source-era walkthrough of sequence input and structural output
GPT-4oThe announced text, vision, audio, and video capabilities
Interface designVoice, visual assistance, translation, and screen context
ClosingWhere scientific models and multimodal assistants might create value

The central takeaway

AlphaFold 3 and GPT-4o reduce different kinds of friction. A scientific model needs benchmark, uncertainty, and experimental validation. A multimodal assistant needs task, privacy, consent, reliability, and recovery testing.

Source note

The preserved raw file is a recovered Google Drive production outline with expanded scripted passages. It is not a timestamped verbatim transcript, so these notes use segment names rather than invented timecodes. Unsupported claims in that outline remain preserved in the raw source and are corrected in E016 Sources.

Listen

Listen on Spotify or watch on YouTube.

TranscriptRead the full conversation.

Ep16 AlphaFold 3 and GPT-4o: Revolutionizing Drug Discovery and AI Capabilities

Transcript

AlphaFold 3 and GPT-4o: Revolutionizing Drug Discovery and AI Capabilities Welcome to Venture Step podcast where we discuss entrepreneurship, industry trends, and the occasional book review. First, we'll be discussing AlphaFold 3, a protein structure prediction model that's accelerating drug discovery and driving scientific breakthroughs. Then, we'll be exploring GPT-4o, a multimodal AI model that's pushing the boundaries of vision, voice, and text capabilities. Host Intro: "Before we dive in, I'm Dalton. My background is a mix: of programming and data science, and insurance. Offline, you might find me running, building my side business, or lost in a good book. You can listen to the podcast in video or audio format on Spotify or YouTube and listen to the audio on Apple Podcast. Segment 1: Introduction (2 minutes) Briefly introduce the topic and explain that we will be discussing two groundbreaking AI models: AlphaFold 3 and GPT-4o Explain that AlphaFold 3 is a protein structure prediction model, while GPT-4o is a multimodal AI model with capabilities in vision, voice, and text Segment 2: AlphaFold 3 Advancements (10 minutes) Discuss the advancements of AlphaFold 3, including: Improved accuracy The big jump between AlphaFold 2 and AlphaFold 3 lies in the following advancements: Improved accuracy: AlphaFold 3 demonstrates significant improvements in predicting protein structures, particularly for challenging cases like multidomain proteins and complexes. Expanded capabilities (protein-nucleic acid complexes, protein-small molecule interactions, ions and modified residues) Expanded capabilities: AlphaFold 3 can now handle more complex systems, including: Protein-nucleic acid complexes (e.g., protein-DNA, protein-RNA) Protein-small molecule interactions Ions and modified residues Enhanced scalability Enhanced scalability: AlphaFold 3 can process larger and more complex systems, making it a powerful tool for exploring biological mechanisms and drug discovery. New diffusion-based architecture New diffusion-based architecture: AlphaFold 3 introduces a novel diffusion-based approach, replacing the traditional transformer-based architecture. This change enables better handling of long-range interactions and more accurate predictions. Faster and more efficient: AlphaFold 3 is optimized for speed and efficiency, allowing researchers to simulate and analyze complex biological systems faster. These advancements make AlphaFold 3 a groundbreaking tool for understanding biological systems, accelerating drug discovery, and driving scientific breakthroughs. Faster and more efficient processing Faster and more accurate predictions: AlphaFold 3 can predict protein structures and dynamics in hours, compared to traditional methods that can take weeks or even months. Explain how these advancements make AlphaFold 3 a groundbreaking tool for understanding biological systems, accelerating drug discovery, and driving scientific breakthroughs. Improved drug design: With more accurate protein structures, researchers can design more effective drugs with fewer side effects. New drug targets: AlphaFold 3 can identify potential drug targets that were previously unknown or difficult to predict. This breakthrough has far-reaching implications for various fields, including: Drug discovery: AlphaFold 3 can accelerate the development of new drugs for various diseases. Basic research: It can help researchers understand biological processes and protein function at an unprecedented level. Biotechnology: It can be used to design new biomolecules and materials with specific properties. Segment 3: AlphaFold 3 Impact and Value Creation (10 minutes) Discuss the impact of AlphaFold 3 on drug discovery and development, including: Accelerated timelines Improved drug efficacy and safety New drug targets and therapies Enhanced understanding of biological systems AlphaFold 3's success marks a significant shift in the field, demonstrating the power of machine learning in understanding complex biological systems. Isomorphic Labs, a subsidiary of DeepMind, owns the intellectual property (IP) rights to AlphaFold 3. This positions Google, DeepMind's parent company, favorably in the following ways: Leadership in AI for drug discovery: Google solidifies its position as a leader in applying AI to drug discovery and life sciences, enhancing its reputation and influence in the field. Commercialization opportunities: Isomorphic Labs can license AlphaFold 3 to pharmaceutical companies, research institutions, and biotechs, generating revenue and creating a new business stream for Google. Strategic partnerships: Google can form partnerships with key players in the pharmaceutical and biotech industries, driving collaborations and further advancing drug discovery and development. Data and knowledge graph expansion: AlphaFold 3's applications will generate vast amounts of data, which can be integrated into Google's knowledge graph, enhancing its capabilities and creating new opportunities for data analysis and insights. Accelerated drug discovery: AlphaFold 3 can significantly reduce the time and cost associated with drug discovery, potentially saving billions of dollars and years of research. Improved drug efficacy and safety: By more accurately predicting protein structures and dynamics, AlphaFold 3 can help design drugs with better efficacy and fewer side effects. New drug targets and therapies: AlphaFold 3 can identify novel drug targets and enable the development of new therapies for previously intractable diseases. Enhanced understanding of biological systems: AlphaFold 3's applications can lead to a deeper understanding of biological processes, driving breakthroughs in precision medicine and regenerative biology. The value creation potential of AlphaFold 3 is substantial, with estimates suggesting it could: Reduce drug discovery costs by 50-70% Accelerate drug development timelines by 2-5 years Lead to the discovery of new drugs and therapies worth tens of billions of dollars By owning the IP rights to AlphaFold 3, Google is well-positioned to capitalize on these opportunities and drive innovation in the life sciences sector. Estimate the value creation potential of AlphaFold 3, including reduced drug discovery costs and accelerated development timelines Segment 5: AlphaFold 3 Live demo Input: You provide a sequence of amino acids (for proteins) or nucleotides (for nucleic acids) to the AlphaFold 3 server. Embedding: The input sequence is converted into a numerical representation using a technique called embedding. This allows the model to process the sequence as a mathematical object. Diffusion-based architecture: AlphaFold 3 uses a novel diffusion-based architecture, which is a type of neural network. This architecture consists of multiple layers that progressively refine the prediction of the 3D structure. Structure prediction: The model predicts the 3D structure of the input sequence, including the positions of atoms, bonds, and angles. Refinement: The predicted structure is refined through a process called relaxation, which minimizes energy and optimizes the structure. When testing on the AlphaFold 3 server, look for: Sequence input: Enter the sequence of amino acids or nucleotides you want to predict the structure for. Model selection: Choose the appropriate model (e.g., protein, nucleic acid, or complex) and parameters (e.g., resolution, accuracy). Job submission: Submit the job and wait for the results. Structure visualization: Visualize the predicted 3D structure using tools like PyMOL, Chimera, or Jmol. To understand interactions between biomolecules (proteins, lipids, carbohydrates, nucleotides, and nucleic acids), look for: Binding sites: Identify regions on the protein or nucleic acid surface where other molecules can bind. Intermolecular contacts: Analyze the predicted structure to identify contacts between atoms, residues, or molecules. Hydrogen bonding: Identify hydrogen bonds between molecules, which are crucial for stability and interactions. Electrostatic interactions: Analyze the electrostatic potential surface to identify areas of positive and negative charge, which can influence interactions. Conformational changes: Study how the predicted structure changes upon binding or interaction with other molecules. Segment 4: GPT-4o Features and Capabilities (10 minutes) Discuss the features and capabilities of GPT-4o, including: Real-time voice conversation and video streams Text-based interface Merged capabilities for faster responses and smoother transitions Visual problem-solving and reasoning Record-keeping for continuity across conversations Live translation, search, and information lookup GPT-4o Model: OpenAI debuted GPT-4o, a new AI model that you can communicate with in real-time via live voice conversation, video streams from your phone, and text. Key Features: Free for all users through both the GPT app and the web interface Users who subscribe to OpenAI’s paid tiers will be able to make more requests The model is rolling out over the next few weeks GPT-4o has merged capabilities into a single model, which means faster responses and smoother transitions between tasks The model can reason through visual problems in real-time The model will store records of users’ interactions, meaning the model “now has a sense of continuity across all your conversations” Live translation, the ability to search through your conversations with the model, and the power to look up information in real-time are also offered GPT-4o Voice Assistant: A conversational assistant much in the vein of Siri or Alexa but capable of fielding much more complex prompts The voice assistant is fast, conversational, and has Google Lens-like vision The assistant is capable of real-time translations ChatGPT Upgrades: Free ChatGPT users will get access to custom chatbots for the first time The multimodal model will power a new ChatGPT Voice that is more human-like ChatGPT Desktop app launching with voice and vision capabilities Everything will be launching over the coming weeks Other Features: Using an incredibly natural voice, running on a Mac, ChatGPT was able to view code being written and analyze the code The vision capabilities of the ChatGPT Desktop app seem to include the ability to view the desktop The AI is able to see the changes you make and can solve problems Introduce the GPT-4o voice assistant and its capabilities, including real-time translations Segment 5: ChatGPT Upgrades and Other Features (5 minutes) Discuss the upgrades to ChatGPT, including: Custom chatbots for free users Multimodal model powering ChatGPT Voice ChatGPT Desktop app with voice and vision capabilities Mention other features, including the ability to view and analyze code, and solve problems Segment 6: Conclusion (2 minutes) Summarize the main points discussed in the episode Emphasize the revolutionary potential of AlphaFold 3 and GPT-4o in their respective fields Encourage listeners to explore these models and their applications. Show Links https://blog.google/technology/ai/google-deepmind-isomorphic-alphafold-3-ai-model/ https://golgi.sandbox.google.com/ https://openai.com/index/hello-gpt-4o/

SourcesFollow the source trail.

E016 Sources

The recovered file preserves Dalton's May 2024 production outline and the claims considered for the episode. It is not a verbatim transcript and does not independently validate scientific results, model capabilities, product access, or commercial outcomes.

Source ledger

SourceClassSupportsBoundary
[[E16 - Transcript - Google Drive recovered]]Preserved primary sourceDalton's episode framing, planned segments, interpretations, and source-era claimsRaw body is immutable. It contains unsupported scientific, commercial, ownership, parameter-count, availability, and savings claims.
[[E16 - AlphaFold 3 and GPT-4o - Science and Usability]]Legacy editorial derivativePrior reconstruction of the episode and public linksIt contains expanded claims and AI-heavy formatting. It cannot replace the raw source.
[[AlphaFold 3 and GPT-4o - AI's Leap in Science and Usability]]Legacy public draftPrior public-facing narrativeIt is retained for provenance and superseded by [[E016 Article]].
AlphaFold 3 paperPeer-reviewed primary researchModel scope, architecture, benchmark categories, comparative results, confidence, and limitationsStructure-prediction results do not establish clinical utility, laboratory replacement, economic savings, or every drug-discovery outcome.
Google DeepMind AlphaFold 3 launchFirst-party launch recordCo-development, vendor benchmark summary, AlphaFold Server access at launch, and laboratory-hypothesis framingPromotional interpretation must be separated from the paper's methods and results.
Google DeepMind AlphaFold pageFirst-party product and research pageCurrent AlphaFold access routes and academic code-and-weights availabilityCurrent access differs from the May 2024 launch state and requires periodic refresh.
GPT-4o launchFirst-party launch recordMay 13, 2024 announcement, modality design, vendor latency results, launch availability, and staged rolloutDemonstrated voice and video features were not all generally available at launch. Vendor latency is not a universal service guarantee.
GPT-4o system cardFirst-party safety reportVoice, speaker, accent, sensitive-trait, audio-robustness, and misinformation risksThe evaluations do not establish fitness for every real-world workflow.
GPT-4o ChatGPT retirementFirst-party lifecycle recordFebruary 2026 ordinary ChatGPT retirement and separate API boundaryChatGPT retirement does not establish shutdown of every GPT-4o-related model or API surface.
Current GPT-4o API documentationFirst-party API recordCurrent documented API model, snapshots, endpoints, and deprecation contextAvailability, price, limits, and lifecycle are time-sensitive.
NIST AI RMF Measure guidanceGovernment evaluation frameworkContext-specific testing, evaluation, verification, validation, uncertainty, and domain reviewNIST does not certify AlphaFold 3, GPT-4o, or this evaluation method.
FDA machine-learning transparency principlesGovernment sector guidanceIntended-use, data, performance, limitation, human-AI, and local-validation considerationsThe guidance does not make AlphaFold 3 a medical device or determine a regulatory classification.
Google DeepMind about pageFirst-party company pageGoogle DeepMind identity and research roleMission and impact descriptions are company statements.
OpenAI about pageFirst-party company pageOpenAI identity and missionStructure, leadership, products, and contact routes are time-sensitive.
Isomorphic Labs company siteFirst-party company pageDrug-design focus, company identity, and official contact routesCompany descriptions and performance statements are promotional unless independently supported.

Corrections and boundaries

The Nature paper reports that AlphaFold 3 predicts joint structures for complexes that can contain proteins, nucleic acids, small molecules, ions, and modified residues. It does not claim to predict general molecular dynamics.

The paper reports improvements against specified specialized methods across defined categories. Google DeepMind's statement that AlphaFold 3 was the first AI system to outperform physics-based tools refers to a protein-ligand benchmark comparison. It should not be widened into a claim that the model replaced physics-based modeling.

AlphaFold Server was free for non-commercial research at launch. That did not make the entire AlphaFold 3 release open source. Google DeepMind later made model code and weights available for academic use.

Google DeepMind and Isomorphic Labs co-developed AlphaFold 3. The reviewed sources do not support the outline's claim that Isomorphic Labs solely owned its intellectual property.

The primary sources do not support the outline's estimates of a 50 to 70 percent reduction in discovery costs, a two-to-five-year acceleration, billions of dollars in savings, or guaranteed new therapies. Those claims are excluded from the canonical article.

OpenAI announced GPT-4o on May 13, 2024. At launch, the public release began with text and image inputs and text outputs. The richer voice and video experiences were planned for staged release.

OpenAI retired GPT-4o from ordinary ChatGPT use in February 2026. Current API documentation remains separately available. ChatGPT product retirement, voice systems, image systems, realtime systems, and API lifecycle must not be collapsed.

OpenAI did not disclose a GPT-4o parameter count in the reviewed launch documentation. The outline's claim that the model had more than one trillion parameters is excluded.

The reported 232 millisecond minimum and 320 millisecond average audio response times are OpenAI test results. They are not guaranteed end-to-end latency across devices, networks, regions, tiers, or later products.

Editorial decisions

The public package keeps the shared idea that both systems reduce friction while separating their standards of proof. It treats AlphaFold 3 as a scientific prediction system and GPT-4o as a multimodal interaction model.

The episode-level page is a source-limited record, not a reconstructed spoken story. Dated company-role records avoid duplicating maintained company profiles while preserving who developed, published, released, and applied the systems.

The package does not provide an AlphaFold Server tutorial. A responsible tutorial would require current interface verification, current terms, an appropriate scientific example, and qualified guidance on interpreting confidence and experimental limits.

AlphaFold 3 and GPT-4o: Revolutionizing Drug Discovery and AI Capabil